| 8.00 |
Registration |
| 9.00 |
Welcome and Introduction A. Piaggesi |
| 9.15 |
Opening Lecture Chairman: A. Piaggesi L'epidemiologia del piede diabetico ischemico E. Faglia |
| 9.45-11.00 |
| Pathogenesis |
| Chairman: M. Edmonds |
| 09.45 |
Insulin-resistance, inflammation and PAD A. Ceriello |
| 10.05 |
Peculiarity of the diabetic macroangiopathy M. Edmonds |
| 10.25 |
New markers for an old disease R. Miccoli |
| 10.45 |
Discussion |
|
| 11.00 |
For Debate Is preliminary diagnostic assessment always necessary before intervention? Chairman: E. Minar YES: I. Bargellini NO: J. Clerissi |
| 12.00 |
Sala Perla Symposium Are latest results of coronary Drug Eluting Stent (DES) in diabetic reliable?
Chairman: A. S. Petronio
Discussant: - Coronary artery disease (CAD) in diabetics: epidemiology, outcome, diagnosis A. Piaggesi
-Which Coronary Stent in diabetics: the evidence of numebers F. Airoldi
- The dark side of coronary DES trials: which kind of diabetics have been enrolled? F. Fabbiocchi
- Final Remarks A. S. Petronio
with the support of Abbott Vascular
|
| 13.00 |
Lunch - Exhibition viewing |
| 14.00 |
Lecture Chairman: J. Apelqvist The ischemic diabetic foot in Europe, insights from the Eurodiale Study N. Schaper
|
| 14.30-15.30 |
| Co-morbidity |
| Chairmen: L.Ricci, G.Wolf |
| 14.30 |
The heart-foot syndrome F. Liistro |
| 14.50 |
The head-foot syndrome M. De Carlo |
| 15.10 |
The kidney-foot syndrome G. Wolf |
|
| 15.30-16.30 |
| Medical therapy for the ulcerated ischemic foot |
| Chairman: J. Apelqvist |
| 15.30 |
The anti infective therapy in the ischemic foot F. Menichetti
|
| 15.50 |
The role of metabolic control G. Ghirlanda |
| 16.10 |
New indications for old drugs: the adjuvant therapies revisited L. Uccioli |
|
| 16.30 |
For Debate Antiplatelets vs anticoagulants in the management of the diabetic patients with PAD Chairman: E. Faglia Antiplatelets: J. Dorffler-Melly Anticoagulants: R. De Caterina |
| 17.30-18.30 |
Sala Perla Symposium Premises and Promises of Drug Eluting Balloons (DEB) in peripheral Interventions
Chairman: G. Ansel/ Co- Chairman: B. Scheller
Discussant:
- Drug eluting balloons (DEB)from inception to clinical use B. Scheller
- Long lesion and occlusion in BTK A. Schimdt
- Diabetic hand R. Ferraresi
- Hemodyalisi Shunts P. Pattynama
- Femoral an Popliteal T. Zeller
with the support of Invatec
|
|
April 23, 2010 Salone delle Feste
ISCHEMIC FOOT PROGRAM
|
| 9.00 |
Lecture Chairman: S. van Baal A surgery dedicated to the diabetic foot D. Armstrong |
| 9.30-10.45 |
| Surgical therapy |
| Chairman: A. Piaggesi , S. Van Baal |
| 9.30 |
The perioperative management of diabetic foot patients B. Kuppers |
| 9.50 |
Surgical drainage of the infected foot J. Aragon Sanchez |
| 10.10 |
Surgical reconstructive techniques A. Piaggesi |
| 10.30 |
Discussion |
|
| 10.45 |
Clinical Cases Chairmen: A. Piaggesi, E. Faglia Panelists: G. Clerici, L. Dalla Paola, F. Romagnoli |
| 11.30 |
Lecture Chairman: L. Uccioli Innovative approach to the treatment of severe diabetic foot infection: a new surgical protocol. C. Caravaggi |
| 12.00 |
Sala Perla Symposium The future of V.A.C. ® Therapy
Chairman: A. Piaggesi Discussant:
- VAC Therapy and the Diabetic Foot Scenario A. Piaggesi
- Use of VAC as adjuvant therapy in selected clinical cases L. Dalla Paola
- Making sense of VAC Therapy. Challanges for the future S. Vig
with the support of KCI
|
| 13.00 |
Lunch - Exibition Viewing |
| 14.30 |
Lecture Chairman: G. Ghirlanda The stratification of the risk in the multi-complicated patient J. Apelqvist |
| 15.00 |
New technologies for the management of the diabetic ischemic leg Chairman A. Piaggesi
Frequency- modulated electromagnetic stimulation (FREMS) in the management of the ischemic leg R. Da Ros Nanotecnologies in the treatment for the prevention and rehabilitation of the ischemic leg E. Banchellini
|
| 16.00 |
For Debate Does revascularization always precede surgery? Chairman: D. Armstrong Yes: S. Van Baal No:G. Clerici |